Upstream Bio, Inc. · NASDAQ:UPB
Deykin Aaron sold 895 Upstream Bio, Inc. shares (Form 4)
Traded Sep 16, 2026 · Filed Sep 17, 2026
On Sep 16, 2026, Deykin Aaron (Chief Medical Officer) sold 895 Upstream Bio, Inc. shares at US$5.49 for US$4,914, leaving 32,302 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 895 shares
- Price
- US$5.49
- Value
- US$4,914
- Holding after
- 32,302 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | Sale | 895 | US$5.49 | 32,302 | Direct |